Dry Powder Inhaler Market Share To Witness Steady Rise In Coming Decade : Fact.MR

According to a recent report by Fact.MR, a market research and competitive intelligence provider, the global dry powder inhaler market is valued at around US$ 857 Mn, and is projected to expand at a CAGR of around 7.2% through the end of 2031.

Dry powder inhalers are used to treat respiratory diseases such as asthma, bronchitis, emphysema, etc., helping deliver medication to the lungs in the powdered form. Conventional devices such as metered-dose inhalers are being replaced with DPIs, being a finer alternative. On a global scale, escalating gasping diseases such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, asthma, etc., is a major driver for the global dry powder inhaler market.

For critical insights on this market, request for More Info – https://www.factmr.com/connectus/sample?flag=S&rep_id=7083

Key Segments Covered in Dry Powder Inhaler Industry Research

• By Product Type

  • Capsule-based Devices
  • Blister-based Devices
  • Reservoir/Cartridge-based Devices
  • Others

• By Application

  • Bronchitis
  • Chronic Obstructive Pulmonary Diseases (COPD)
  • Asthma
  • Others

• By Sales Channel

  • Offline Channels
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Other Sales Channels
  • Online Channels

• By Region

  • North America Dry Powder Inhaler Market
  • Latin America Dry Powder Inhaler Market
  • Europe Dry Powder Inhaler Market
  • South Asia Dry Powder Inhaler Market
  • East Asia Dry Powder Inhaler Market
  • Oceania Dry Powder Inhaler Market
  • Middle East Africa Dry Powder Inhaler Market

Request more information about Report Methodology – https://www.factmr.com/connectus/sample?flag=RM&rep_id=7083

Key Takeaways from Market Study

• Rising pollution and respiratory diseases is a key factor driving demand for dry powder inhalers at 7.2% CAGR.
• Among the product types, capsule-based inhalers will be the fastest-growing segment owing to simplicity and efficiency of their use.
• North America is set to dominate market revenue, followed by key countries in Europe such as the U.K. and Germany.

Who is Winning?

At this point, there is a rise in different respiratory problems attributed to the widespread of coronavirus. Thus, dry powder inhaler manufacturers have increased their operations in order to meet the requirements of their customers.

Some of the leading companies offering dry powder inhalers are AstraZeneca, GlaxoSmithKline Plc, Vectura Group Plc, Boehringer Ingelheim GmbH, Otsuka Pharmaceutical Co. Ltd., Norton Healthcare, Respira Therapeutics, Inc, Cheisi, and Cipla.

For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7083

Get More Valuable Insights

Fact.MR, in its new offering, provides an unbiased analysis of the demand for dry powder inhaler market presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031.

The study divulges compelling insights on the demand for dry powder inhalers based on product type (capsule-based devices, blister-based devices, reservoir/cartridge-based devices, and others), application (bronchitis, chronic obstructive pulmonary diseases (COPD), asthma, and others), and sales channel (offline and online), across seven major regions of the world (North America, Latin America, Europe, South Asia, East Asia, Oceania, and MEA).

For More Insight- https://www.einpresswire.com/article/557298123/demand-for-independent-front-suspension-is-estimated-to-remain-high-owing-to-the-system-of-better-handling-stability

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: [email protected]
Visit Our Website: https://www.factmr.com